Treatment patterns and clinical outcomes in patients with metastatic colorectal cancer initially treated with FOLFOX-bevacizumab or FOLFIRI-bevacizumab: results from ARIES, a bevacizumab observational cohort study.

Treatment patterns and clinical outcomes in patients with metastatic colorectal cancer initially treated with FOLFOX-bevacizumab or FOLFIRI-bevacizumab: results from ARIES, a bevacizumab observational cohort study. Oncologist. 2012; 17(12):1486-95.

View in: PubMed

subject areas

Adolescent
Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols
Bevacizumab
Camptothecin
Colorectal Neoplasms
Disease-Free Survival
Female
Fluorouracil
Humans
Leucovorin
Longitudinal Studies
Male
Middle Aged
Neoplasm Metastasis
Organoplatinum Compounds
Prospective Studies
Treatment Outcome
Young Adult

authors with profiles

Mark Kozloff